Evidence map›Paper›PMID 22203966›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

High-resolution dose-response screening using droplet-based microfluidics.

Oliver J Miller, Abdeslam El Harrak, Thomas Mangeat, Jean-Christophe Baret, Lucas Frenz, Bachir El Debs, Estelle Mayot, Michael L Samuels, Eamonn K Rooney, Pierre Dieu and 3 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed.

  1. Article
  2. Article
  3. Droplet-Based Microfluidics Methods for Detecting Enzyme Inhibitors.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Oliver J MillerInstitut de Science et d'Ingénierie Supramoléculaires, Université de Strasbourg, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7006, 8 allée Gaspard Monge, F-67083 Strasbourg Cedex, France.
Abdeslam El Harrak
Thomas Mangeat
Jean-Christophe Baret
Lucas Frenz
Bachir El Debs
Estelle Mayot
Michael L Samuels
Eamonn K Rooney
Pierre Dieu
Martin Galvan
Darren R Link
Andrew D Griffiths

Funding

Droplet based screening of molecular libraries in a microfluidic deviceR44HG003925 · NHGRI · RAINDANCE TECHNOLOGIES, INC. · PI LINK, DARREN R · 2009 to 2010
$748k
NHGRI NIH HHS 5R44HG003925-04NHGRI NIH HHS R44 HG003925
6 · The paper itself

Abstract

A critical early step in drug discovery is the screening of a chemical library. Typically, promising compounds are identified in a primary screen and then more fully characterized in a dose-response analysis with 7-10 data points per compound. Here, we describe a robust microfluidic approach that increases the number of data points to approximately 10,000 per compound. The system exploits Taylor-Aris dispersion to create concentration gradients, which are then segmented into picoliter microreactors by droplet-based microfluidics. The large number of data points results in IC(50) values that are highly precise (± 2.40% at 95% confidence) and highly reproducible (CV = 2.45%, n = 16). In addition, the high resolution of the data reveals complex dose-response relationships unambiguously. We used this system to screen a chemical library of 704 compounds against protein tyrosine phosphatase 1B, a diabetes, obesity, and cancer target. We identified a number of novel inhibitors, the most potent being sodium cefsulodine, which has an IC(50) of 27 ± 0.83 μM.

Indexed as

Dose-Response Relationship, DrugSmall Molecule Librariesbeta-GalactosidaseCefsulodinChromatography, High Pressure LiquidDrug DiscoveryDrug Evaluation, PreclinicalFluorescenceInhibitory Concentration 50MicrofluidicsProtein Tyrosine Phosphatase, Non-Receptor Type 1Sample Sizebeta-GalactosidaseCefsulodinProtein Tyrosine Phosphatase, Non-Receptor Type 1Small Molecule Libraries

Identifiers

PMID22203966
PMCPMC3258639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.